Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3.

Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, Saeki Y, Nita M, Berens ME, Sander LM, Newton HB, Chiocca EA, Lawler S.

Neuro Oncol. 2008 Oct;10(5):690-9. doi: 10.1215/15228517-2008-041. Epub 2008 Aug 20.

2.

Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.

Atkins RJ, Dimou J, Paradiso L, Morokoff AP, Kaye AH, Drummond KJ, Hovens CM.

J Clin Neurosci. 2012 Nov;19(11):1558-63. doi: 10.1016/j.jocn.2012.07.002. Epub 2012 Sep 19.

PMID:
22999562
3.

Polarized regulation of glycogen synthase kinase-3β is important for glioma cell invasion.

Zou Q, Hou Y, Shen F, Wang Y.

PLoS One. 2013 Dec 3;8(12):e81814. doi: 10.1371/journal.pone.0081814. eCollection 2013.

4.

Cell migration in paediatric glioma; characterisation and potential therapeutic targeting.

Cockle JV, Picton S, Levesley J, Ilett E, Carcaboso AM, Short S, Steel LP, Melcher A, Lawler SE, Brüning-Richardson A.

Br J Cancer. 2015 Feb 17;112(4):693-703. doi: 10.1038/bjc.2015.16. Epub 2015 Jan 27.

5.

Glycogen synthase kinases-3beta controls differentiation of malignant glioma cells.

Li Y, Lu H, Huang Y, Xiao R, Cai X, He S, Yan G.

Int J Cancer. 2010 Sep 1;127(6):1271-82. doi: 10.1002/ijc.25020.

6.

Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments.

Williams SP, Nowicki MO, Liu F, Press R, Godlewski J, Abdel-Rasoul M, Kaur B, Fernandez SA, Chiocca EA, Lawler SE.

Cancer Res. 2011 Aug 15;71(16):5374-80. doi: 10.1158/0008-5472.CAN-10-3026. Epub 2011 Jun 22.

7.

Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.

Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H.

Ann Surg Oncol. 2009 Feb;16(2):481-6. doi: 10.1245/s10434-008-0194-6. Epub 2008 Nov 22.

8.

HaCaT keratinocyte migration is dependent on epidermal growth factor receptor signaling and glycogen synthase kinase-3alpha.

Koivisto L, Jiang G, Häkkinen L, Chan B, Larjava H.

Exp Cell Res. 2006 Sep 10;312(15):2791-805. Epub 2006 May 24.

PMID:
16806170
10.

Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.

Selenica ML, Jensen HS, Larsen AK, Pedersen ML, Helboe L, Leist M, Lotharius J.

Br J Pharmacol. 2007 Nov;152(6):959-79. Epub 2007 Oct 1.

11.

Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.

Lamarre M, Desrosiers RR.

Neuropharmacology. 2008 Oct;55(5):669-76. doi: 10.1016/j.neuropharm.2008.05.033. Epub 2008 Jun 6.

PMID:
18582478
12.

Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.

Yeste-Velasco M, Folch J, Trullàs R, Abad MA, Enguita M, Pallàs M, Camins A.

Neuropharmacology. 2007 Aug;53(2):295-307. Epub 2007 May 26.

PMID:
17612578
13.

Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy.

Xu CS, Wang ZF, Dai LM, Chu SH, Gong LL, Yang MH, Li ZQ.

J Transl Med. 2014 May 27;12:148. doi: 10.1186/1479-5876-12-148.

14.

Lithium chloride decreases proliferation and migration of C6 glioma cells harboring isocitrate dehydrogenase 2 mutant via GSK-3β.

Fu Y, Zheng Y, Chan KG, Liang A, Hu F.

Mol Biol Rep. 2014 Jun;41(6):3907-13. doi: 10.1007/s11033-014-3258-7. Epub 2014 Feb 19.

PMID:
24549719
15.

Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.

Jane EP, Premkumar DR, Pollack IF.

J Pharmacol Exp Ther. 2006 Dec;319(3):1070-80. Epub 2006 Sep 7.

16.

The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.

Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM.

Mol Psychiatry. 2009 Jan;14(1):51-9. Epub 2007 Oct 9.

PMID:
17925795
17.

Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.

Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS.

J Biol Chem. 2003 Aug 29;278(35):33067-77. Epub 2003 Jun 7.

18.

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

Chen G, Huang LD, Jiang YM, Manji HK.

J Neurochem. 1999 Mar;72(3):1327-30.

19.

LAP3 promotes glioma progression by regulating proliferation, migration and invasion of glioma cells.

He X, Huang Q, Qiu X, Liu X, Sun G, Guo J, Ding Z, Yang L, Ban N, Tao T, Wang D.

Int J Biol Macromol. 2015 Jan;72:1081-9. doi: 10.1016/j.ijbiomac.2014.10.021. Epub 2014 Oct 24.

PMID:
25453285
20.

Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor.

Zhang W, Law RE, Hinton DR, Couldwell WT.

Cancer Lett. 1997 Nov 25;120(1):31-8.

PMID:
9570383

Supplemental Content

Support Center